Five arrested on suspicion of drug supply offences as pharmacy investigated for serious risk to patient safety
“Following information received from Lancashire Police, an inspection of the pharmacy on 2 October 2026 found system wide failures which presents a serious risk to patient safety.”
Five people have been arrested on suspicion of drug supply offences in connection with a Fylde coast pharmacy.
The regulatory body for pharmacies, the General Pharmaceutical Council (GPhC), has also spalled Acer Pharmacy, of St George’s Lane, Cleveleys, with an Improvement Notice after an inspection into the pharmacy uncovered “system wide failures which present a serious risk to patient safety”.
Bosses at Northwest Pharmacy Ltd, which trades as Acer Pharmacy, said they are “cooperating fully” with the GPhC investigation and take the safety of their customers “extremely seriously”.


Lancashire Police confirmed to The Gazette earlier today that five arrests have been made as part of an ongoing investigation which is connected to Acer Pharmacy. Four men, aged 33, 38, 36 and 31; and a woman, aged 22, were arrested on suspicion of drug supply offences.
Three of the arrests were made on October 1, one was made on October 16, and one was made on November 8. All five have since been bailed with conditions pending further enquiries, police said.
The General Pharmaceutical Council investigation - which took place on October 2 after being triggered by a tip-off from Lancashire Police - found that Acer Pharmacy failed six premises standards. A subsequent Improvement Notice was issued to the Cleveleys business on November 13.


Enjoy unlimited access to local news, the latest football stories and new puzzles every day
With a digital subscription, you can see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Click here to subscribe
The Improvement Notice’s summary reads: “Following information received from Lancashire Police, an inspection of the pharmacy on 2 October 2026 found system wide failures which presents a serious risk to patient safety.
“The risks are heightened by the nature of the services provided including the employment of team members without adequate checks being completed to ensure vulnerable people are adequately protected, and the pharmacy is unable to demonstrate how it mitigates the risk with its team members delivering medicines to people’s chosen addresses.
“It is also unable to demonstrate how it has effective governance arrangements in place to provide services in a safe and effective manner including safe medicines management, keeping adequate records in line with legal requirements and providing pharmacy services from a suitable premises. The concerns identified fall below the standards expected and increase the risk to patient and public safety.”


The GPhC has instructed Acer Pharmacy to do the following by December 12, 2026:
- Improve management and oversight
- Tighten medicines security
- Update controlled drug records
- Carry out weekly drug checks
- Report drug discrepancies
- Restrict access to drug cabinets and strengthen staff recruitment checks
In response to the investigations led by the GPhC and Lancashire Police, a spokesman for Northwest Pharmacy Ltd - which trades as Acer Pharmacy - said: “We can confirm that the General Pharmaceutical Council has served an improvement notice on Northwest Pharmacy Ltd, trading as Acer Pharmacy, dated 13 November 2026.


All the latest news and top stories from across Blackpool and the Fylde coast directly to your phone.
Never miss a thing. Click here to join
“We take our regulatory obligations and the safety of the people who rely on our services extremely seriously. We are cooperating fully with the GPhC and are working through the matters raised in the notice as a matter of priority.
“A detailed action plan is in place, and we are committed to completing the required measures within the timeframe set by the regulator.
“We would like to reassure our patients that our service continues as normal. All prescriptions continue to be delivered safely and on time, and we have recently moved to a dedicated third-party delivery company to support our home delivery service.
“Our priority throughout remains the safe and reliable supply of medicines to the people who depend on us, and we are taking every step to ensure that service continues without interruption.”